$PRLB

Proto Labs Inc (PRLB): Protolabs Reports Financial Results for the Third Quarter of 2026

Proto Labs Inc (PRLB) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Protolabs Reports Financial Results for the Third Quarter of 2026 Record Quarterly Revenue of $154.3 Million, a 14.0% Increase Year-Over-Year GAAP Earnings Per Share of $0.48, up 61% YoY; Non-GAAP Earnings Per Share of $0.63, up 33% YoY Raising Full Year 2026 Revenue

Original reporting
Published Oct 29, 2026, 10:06 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 10:08 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$PRLB
Bullish
high confidence
Mentioned
$PRLB
Relevance
8/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$PRLBBullishHigh
01

Why it matters

The raised guidance may attract growth‑oriented investors and support a price rally.

02

Market read

The earnings beat and guidance raise are the primary catalysts for PRLB's near‑term price action.

03

What to watch

Potential supply‑chain constraints could limit margin expansion despite revenue growth.

Relevance 8/10Novelty 8/10Timing: after-hours release
AlphAI · Earnings readPRLB · Third Quarter 2026 · ended September 30, 2026

Record Quarterly Revenue of $154.3 Million, a 14.0% Increase Year-Over-Year; GAAP Earnings Per Share of $0.48, up 61% YoY; Non-GAAP Earnings Per Share of $0.63, up 33% YoY; Raising Full Year 2026 Revenue Growth Guidance from 8% - 10% to 10% - 11%

✓Strong quarter

Third-quarter revenue reached a record $154.3 million with 14.0% year-over-year growth, all major product lines except Sheet Metal grew, and GAAP and non-GAAP operating margins expanded. GAAP diluted EPS rose to $0.48 from $0.30, while the Company raised full-year revenue growth guidance to between 10% and 11%.

Revenue
$154M
14.0% y/y
Injection Molding
$53.7M
12.5 % y/y
Gross margin · GAAP
44.5 %
EPS · non-GAAP
$0.63
33% y/y
Full year 2026 and Q4 2026 outlook
Full year 2026 revenue growth between 10% and 11%; Q4 2026 revenue between $143.0 million and $151.0 million

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Q3 2026 total revenueGAAP$154.3M–14.0%
Nine months ended September 30, 2026 total revenueGAAP$443.0M–11.7%
Q3 2026 gross profitGAAP$68.66M––
Q3 2026 GAAP gross marginGAAP44.5 %––
Q3 2026 non-GAAP gross profitnon-GAAP$68.75M––
Q3 2026 non-GAAP gross marginnon-GAAP44.5 %––
Nine months ended September 30, 2026 GAAP gross marginGAAP45.5 %––
Nine months ended September 30, 2026 non-GAAP gross marginnon-GAAP45.8 %––
Q3 2026 cost of revenueGAAP$85.66M––
Q3 2026 marketing and sales expenseGAAP$24.53M––
Q3 2026 research and development expenseGAAP$11.02M––
Q3 2026 general and administrative expenseGAAP$18.24M––
Q3 2026 restructuring and transformation costsGAAP$434K––
Q3 2026 total operating expensesGAAP$54.22M––
Q3 2026 income from operationsGAAP$14.44M––
Q3 2026 GAAP operating marginGAAP9.4 %––
Q3 2026 non-GAAP income from operationsnon-GAAP$18.42M––
Q3 2026 non-GAAP operating marginnon-GAAP11.9 %––
Nine months ended September 30, 2026 income from operationsGAAP$35.64M––
Nine months ended September 30, 2026 GAAP operating marginGAAP8.0 %––
Nine months ended September 30, 2026 non-GAAP income from operationsnon-GAAP$51.70M––
Nine months ended September 30, 2026 non-GAAP operating marginnon-GAAP11.7 %––
Q3 2026 net incomeGAAP$11.76M–63.0%
Q3 2026 GAAP net income marginGAAP7.6 %––
Q3 2026 diluted net income per shareGAAP$0.48–61%
Q3 2026 non-GAAP net incomenon-GAAP$15.34M––
Q3 2026 non-GAAP diluted net income per sharenon-GAAP$0.63–33%
Nine months ended September 30, 2026 net incomeGAAP$29.02M––
Nine months ended September 30, 2026 diluted net income per shareGAAP$1.19––
Nine months ended September 30, 2026 non-GAAP net incomenon-GAAP$43.12M––
Nine months ended September 30, 2026 non-GAAP diluted net income per sharenon-GAAP$1.77––
Q3 2026 adjusted EBITDAnon-GAAP$26.16M–23.8%
Q3 2026 adjusted EBITDA marginnon-GAAP17.0 %––
Nine months ended September 30, 2026 adjusted EBITDAnon-GAAP$74.06M––
Nine months ended September 30, 2026 adjusted EBITDA marginnon-GAAP16.7 %––
Q3 2026 customer contactsother20,777––
Q3 2026 revenue per customer contactother$7,427–16.6%
Nine months ended September 30, 2026 customer contactsother40,129––
Nine months ended September 30, 2026 revenue per customer contactother$11,039––

Segments

SegmentRevenueq/qy/y
Injection MoldingQ3 2026 GAAP revenue; constant-currency revenue was $53,776 (in thousands) and organic growth was 12.6 %.$53.73M–12.5 %
CNC MachiningQ3 2026 GAAP revenue; constant-currency revenue was $73,543 (in thousands) and organic growth was 16.7 %.$73.36M–16.4 %
3D PrintingQ3 2026 GAAP revenue; constant-currency revenue was $22,393 (in thousands) and organic growth was 11.5 %.$22.36M–11.4 %
Sheet MetalQ3 2026 GAAP revenue; constant-currency revenue was $4,065 (in thousands) and organic growth was (4.6) %.$4.06M–(4.7) %
Other RevenueQ3 2026 GAAP revenue; constant-currency revenue was $808 (in thousands) and organic growth was 286.6 %.$802K–283.7 %
United StatesQ3 2026 GAAP revenue; non-GAAP revenue was $125,412 (in thousands) and organic growth was 14.7 %.$125.4M–14.7 %
EuropeQ3 2026 GAAP revenue; non-GAAP revenue was $29,173 (in thousands) and organic growth was 12.2 %.$28.91M–11.2 %

Amounts quoted below without a unit are in thousands, as in the filing’s tables. Per-share figures are as printed.

Full year 2026 and Q4 2026 outlook

  • RevenueFull year 2026 revenue growth between 10% and 11%; Q4 2026 revenue between $143.0 million and $151.0 million
  • NoteQ4 2026 GAAP diluted net income per share between $0.28 and $0.36.
  • NoteQ4 2026 non-GAAP diluted net income per share between $0.46 and $0.54.

Capital returns

  • Repurchases of common stock were $10,038 (in thousands) for the nine months ended September 30, 2026, compared to $36,732 (in thousands) for the nine months ended September 30, 2025.
  • Purchases of shares withheld for tax obligations were $6,083 (in thousands) for the nine months ended September 30, 2026, compared to $3,119 (in thousands) for the nine months ended September 30, 2025.
  • Proceeds from issuance of common stock from equity plans were $8,011 (in thousands) for the nine months ended September 30, 2026, compared to $4,195 (in thousands) for the nine months ended September 30, 2025.

What drove it

  • Q3 total revenue per customer contact increased 16.6% year-over-year to $7,427, while customer contacts were 20,777 compared with 21,252.
  • CNC Machining revenue grew 16.4%, Injection Molding revenue grew 12.5%, and 3D Printing revenue grew 11.4% year-over-year.
  • United States revenue increased 14.7% and Europe revenue increased 11.2%; Europe organic growth was 12.2%.
  • GAAP operating margin expanded to 9.4 % from 6.5 %, and non-GAAP operating margin expanded to 11.9 % from 10.0 %.
  • Adjusted EBITDA margin increased to 17.0 % from 15.6 %.

Concerns

  • Sheet Metal revenue declined (4.7) % year-over-year to $4,063 (in thousands).
  • Q3 GAAP gross margin was 44.5 %, compared with 45.3 % in the third quarter of 2025; Q3 non-GAAP gross margin was 44.5 %, compared with 45.9 %.
  • Customer contacts were 20,777 in Q3 2026 compared with 21,252 in Q3 2025.
  • Restructuring and transformation costs were $434 (in thousands) in Q3 2026 and $2,779 (in thousands) for the nine months ended September 30, 2026.

What to watch

  • Q4 2026 revenue outlook of between $143.0 million and $151.0 million.
  • Q4 2026 GAAP diluted net income per share outlook of between $0.28 and $0.36 and non-GAAP diluted net income per share outlook of between $0.46 and $0.54.
  • Execution against raised full-year 2026 revenue growth guidance of between 10% and 11%.
  • Whether growth in CNC Machining, Injection Molding and 3D Printing continues while Sheet Metal revenue remains below the prior-year period.
  • Gross-margin performance following Q3 GAAP gross margin of 44.5 % and non-GAAP gross margin of 44.5 %.

Balance sheet and cash flow

  • Cash and cash equivalents were $133,780 (in thousands) as of September 30, 2026, compared to $110,826 (in thousands) as of December 31, 2025.
  • Short-term marketable securities were $17,366 (in thousands) and long-term marketable securities were $23,903 (in thousands) as of September 30, 2026.
  • Cash and investments balance was $175.0 million as of September 30, 2026.
  • Total assets were $808,021 (in thousands) and shareholders' equity was $701,804 (in thousands) as of September 30, 2026.
  • Total current liabilities were $76,617 (in thousands) as of September 30, 2026.
  • Net cash provided by operating activities was $55,746 (in thousands) for the nine months ended September 30, 2026, compared to $57,874 (in thousands) for the nine months ended September 30, 2025.
  • Purchases of property, equipment and other capital assets were $15,539 (in thousands) for the nine months ended September 30, 2026, compared to $6,792 (in thousands) for the nine months ended September 30, 2025.
  • Net cash used in investing activities was $24,292 (in thousands) and net cash used in financing activities was $8,297 (in thousands) for the nine months ended September 30, 2026.
  • Cash generated from operations was $22.8 million.

Analysis

Protolabs reported record third-quarter revenue of $154.3 million, up 14.0% year-over-year. Revenue growth was broad across the principal product lines, led by CNC Machining at 16.4%, followed by Injection Molding at 12.5% and 3D Printing at 11.4%. United States revenue rose 14.7% and Europe revenue rose 11.2%. Sheet Metal was the exception, declining (4.7) % year-over-year.

The reported growth was driven by higher revenue per customer contact rather than a higher customer-contact count. Q3 revenue per customer contact increased 16.6% to $7,427, while customer contacts were 20,777 compared with 21,252 in the prior-year quarter. The mix and economics of that activity produced lower gross margins, with GAAP gross margin at 44.5 % versus 45.3 %, but operating profitability improved sharply.

GAAP operating margin expanded to 9.4 % from 6.5 %, while non-GAAP operating margin rose to 11.9 % from 10.0 %. GAAP net income increased to $11,762 (in thousands) from $7,216 (in thousands), and diluted EPS increased to $0.48 from $0.30. Non-GAAP diluted EPS increased to $0.63 from $0.47. Adjusted EBITDA increased to $26,165 (in thousands), and adjusted EBITDA margin rose to 17.0 % from 15.6 %.

For the nine months ended September 30, 2026, revenue was $442,995 (in thousands), up 11.7%, and net cash provided by operating activities was $55,746 (in thousands), compared with $57,874 (in thousands) in the prior-year period. The Company held cash and investments of $175.0 million as of September 30, 2026, while spending $10,038 (in thousands) on common-stock repurchases during the nine-month period.

Management raised full-year 2026 revenue growth guidance from 8% - 10% to between 10% and 11%. For Q4, it expects revenue between $143.0 million and $151.0 million, GAAP diluted EPS between $0.28 and $0.36, and non-GAAP diluted EPS between $0.46 and $0.54. The principal reported watchpoints are sustaining double-digit growth in the largest product lines, reversing the Sheet Metal decline, and managing gross-margin performance while maintaining operating leverage.

Management, verbatim

Protolabs delivered another record quarter, with double-digit revenue growth for the fourth consecutive quarter.

Suresh Krishna, President and Chief Executive Officer

Our momentum reflects strong execution and growing demand from industries that value speed, quality, and manufacturing agility.

Suresh Krishna, President and Chief Executive Officer

We delivered another quarter of strong financial performance, with broad-based revenue growth, meaningful operating leverage, and continued earnings growth.

Dan Schumacher, Chief Financial Officer

Not in the filing

stated, not guessed
  • Prior-quarter revenue, segment revenue, margins, earnings, cash flow and balance-sheet comparisons were not reported for the Q3 2026 metrics.
  • Free cash flow was not reported.
  • Debt was not reported.
  • Dividend declarations or payments were not reported.
  • A prior outlook section was not provided; therefore no reported actual-versus-prior-guidance comparison is available.
  • Q4 2026 gross-margin, operating-expense and tax-rate guidance were not reported.
  • Q3 2026 cash flow statement detail was not reported; the cash flow statement covers the nine months ended September 30, 2026.

AlphAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Background

Proto Labs (NYSE: PRLB) is a provider of digital manufacturing services, reporting its Q3 2026 results via an SEC Form 8‑K.

Company-level read

Ticker impact

$PRLBBullishHigh confidence
Context

Proto Labs reported record Q3 revenue of $154.3M and raised full‑year 2026 revenue guidance to 10‑11% in its 8‑K filing.

Expected impact

likely upward pressure as investors price in higher revenue growth

Evidence & confidence

The company increased guidance after a 14% YoY revenue jump, indicating momentum that can lift the stock.

Market effects

Strengthens outlook for digital manufacturing and on‑demand production services.

Positive for U.S. industrial tech sector.

Limited to niche manufacturing segment.

Counterpoint

If the guidance raise is already priced in, the stock may face a short‑term pullback.

Key entities

  • Proto Labs Inc.

    Digital manufacturing services provider.

Every PRLB earnings report

This story covers one filing. The ticker page keeps them all: each quarter's reported metrics with year-over-year and sequential comparisons, segments, guidance, and how the numbers landed against the company's own prior outlook.

Related articles

$ARWMed

Arrow Electronics, Methode Electronics, Proto Labs, and SolarEdge Shares Skyrocket, What You Need To Know

Arrow Electronics (ARW), Methode Electronics (MEI), Proto Labs (PRLB), and SolarEdge (SEDG) shares rose after weaker-than-expected U.S. jobs data lowered Treasury yields. The Bureau of Labor Statistics reported nonfarm payrolls increased by 29,000 in September, below expectations. Lower yields ease borrowing costs for industrial companies, but slower hiring may signal economic cooling. SolarEdge's stock is up 5.4% year-to-date but remains 57.9% below its 52-week high.

$PRLBMed

Is Proto Labs (PRLB) Fully Valued As A New COO Reshapes Operations?

Proto Labs (PRLB) appointed Sam Ramahi as Chief Operations Officer, focusing on operational leadership and global supply chain management. The stock has seen a 12-month total shareholder return of 60.09% and a year-to-date return of 55.29%, closing at $79.74. Analysts debate whether the current price reflects its shift, with a fair value estimate of $95.50, citing strong cash generation and growth potential. However, risks include customer concentration and weakness in Europe, and the stock trad

$PRLBLow

Protolabs Names Sam Ramahi COO to Lead Global Manufacturing Operations

Protolabs (PRLB) appointed Sam Ramahi as COO to lead global operations. Ramahi, with 25 years of experience, will oversee supply chain, quality, and continuous improvement. He previously led operations at SIG Group and Jacuzzi. The move supports Protolabs' strategy to expand from prototyping to production, aiming to improve performance and create value for shareholders.

$PRLBHighAI 9/10

Proto Labs (PRLB) Q2 2026 Earnings Call Transcript

Proto Labs (NYSE:PRLB) reported Q2 FY2026 revenue of $149.3 million, up 10.2% in constant currency, and non-GAAP EPS of $0.60. Non-GAAP gross margin rose to 46.8%. Q3 revenue guidance is $145 million to $153 million, with non-GAAP EPS of $0.56 to $0.64. Full-year 2026 revenue growth guidance was raised to 8% to 10%.